Healing & Tissue Repair · Research deep dive
TB-500: the cited literature
Every study referenced in the TB-500 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, TB-500 is studied at 2 mg – 5 mg per administration, typically twice weekly (loading), then weekly. The reference walkthrough below maps each citation to what it actually showed.
References covered
Thymosin β4 activates integrin-linked kinase
Nature, 2004
Tβ4 in tissue regeneration
Ann. NY Acad. Sci., 2012
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for TB-500.